Pharmicell Co., Ltd.
Pharmicell Co., Ltd.
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-Term Follow-up of Patients With Chronic Kidney Disease Treated With Cellgram-CKD | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Not stated | 2026-09-25 | NCT05096182 | |
| Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Recruiting | Not stated | 2026-09-21 | NCT05093881 | |
| Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Recruiting | Phase 3 | 2026-09-21 | NCT04689152 | |
| Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction | Genital Diseases, Male Urogenital Diseases, Sexual Dysfunctions, Psychological, Urogenital Diseases, erectile dysfunction, male reproductive system disorder, physiological sexual disorder, psychiatric disorder | Recruiting | Not stated | 2026-02-24 | NCT07431008 | |
| Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration | acute myocardial infarction | Recruiting | Not applicable | 2026-02-10 | NCT07400458 |